Metformin may curb depression risk in diabetes patients

12/2/2012 | (U.K.)

Type 2 diabetes patients who were on metformin treatment had a reduced risk of mood disorders such as depression, as well as Parkinson's disease and dementia, especially if sulfonylurea drugs were used as an add-on therapy, a study from Taiwan showed. The results appear in BMC Medicine.

View Full Article in: (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ